Drug Pricing Letters, Comments, & Resources
Comments on Centers for Medicare and Medicaid Services Drug Price Negotiation Program (6/20/23) Comments on FSS Pricing Disclosures and Sales Reporting (10/30/19)
Resource Tag: Coalition Letters, Comments, & Resources
VA Pharmaceuticals Letters, Comments, & Resources
Temporary Suspension of Visits by Drug Representatives Policy Letter (8/4/21) Resale of Drugs through the FSS Program (2/27/18) VA Proposed Rule on Drug and Drug-Related Supply Promotion by Pharmaceutical Sales-
Economic Price Adjustment Letters, Comments, & Resources
Coalition Letter to GSA on Rising Memory Costs (3/24/26) Coalition Comments on Federal Supply Schedule Economic Price Adjustment Rule Change (1/16/24) Letter to GSA on “Highly Competitive” in MAS Solicitation
Value Added Resellers Letters, Comments, & Resources
Coalition Letter Responding to GSA VAR RFI (2/9/26) Attached Feedback on GSA VAR RFI (2/9/26)
Multiple Award Schedule (MAS) Letters, Comments, & Resources
Coalition Letter on Federal Supply Schedule Economic Price Adjustment (01/17/24) Letter to GSA on “Highly Competitive” in MAS Solicitation (5/31/23) Comments on Draft MAS Contractor Assessment Reference Guide (6/22/20) Unpriced
GSA E-Commerce & E-Tools Letters, Comments, & Resources
GSA Commerical Platforms Initiative (CPI) RFI Comments (04/15/2022) Letter to GSA on E-Marketplace Response to E-Commerce Developments (5/22/20) Questions on GSA Commerical Platform Initiative RFP (10/17/19) Comments on Commercial Platform
Transactional Data Reporting (TDR) Letters, Comments, & Resources
Letter on TDR and Firm Fixed Pricing (1/23/26) Letter to GSA FAS Commissioner on Transactional Data Reporting (3/6/23) Comments on Transactional Data Reporting (10/21/22) Transactional Data Reporting Information Collection (7/29/19)
Software Attestation Letters, Comments, & Resources
Comments on Second Draft of CISA’s Secure Software Self-Attestation Form (12/15/23) Comments on CISA’s Secure Software Self-Attestation Form (06/26/23)
FedRAMP Comments, Letters, & Resources
Comments on Draft Memo Modernizing the Federal Risk Authorization Management Program (12/22/2023)
Section 889 Letters, Comments, & Resources
What Federal Contractors Need to Know About Section 889 Section 889 “Part B” Comments (9/11/2020) Comments on GSA Bilateral Modification to Implement Section 889 (9/24/19)